4.25
+0.05(+1.19%)
Currency In USD
| Previous Close | 4.2 |
| Open | 4.18 |
| Day High | 4.3 |
| Day Low | 4.06 |
| 52-Week High | 6.26 |
| 52-Week Low | 0.64 |
| Volume | 68,301 |
| Average Volume | 129,833 |
| Market Cap | 19.34M |
| PE | -3.57 |
| EPS | -1.19 |
| Moving Average 50 Days | 4.5 |
| Moving Average 200 Days | 2.9 |
| Change | 0.05 |
If you invested $1000 in Lixte Biotechnology Holdings, Inc. (LIXT) 10 years ago, it would be worth $101.19 as of December 04, 2025 at a share price of $4.25. Whereas If you bought $1000 worth of Lixte Biotechnology Holdings, Inc. (LIXT) shares 5 years ago, it would be worth $115.49 as of December 04, 2025 at a share price of $4.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
GlobeNewswire Inc.
Nov 25, 2025 1:30 PM GMT
Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to date in developing the technology BOCA RATON, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdin
LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT, LIXTW), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A
LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans
GlobeNewswire Inc.
Oct 16, 2025 12:00 PM GMT
Company underscores clinical execution and confirms advanced negotiations underway on acquisition of complementary oncology assets BOCA RATON, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Na